Financial Snapshot

Revenue
$512.0K
TTM
Gross Margin
34.43%
TTM
Net Earnings
-$1.008M
TTM
Current Assets
Q2 2022
Current Liabilities
Q2 2022
Current Ratio
4.3%
Q2 2022
Total Assets
Q2 2022
Total Liabilities
Q2 2022
Book Value
-$1.815M
Q2 2022
Cash
Q2 2022
P/E
-0.06941
Jul 27, 2023 EST
Free Cash Flow

Revenues

Revenues

Revenue YoY Change

Revenues

Concept 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009

Expenses

Cost Of Revenues

Gross Profit

Gross Profit Margin

Gross Profit

Concept 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009

Selling, General & Admin Expense

Research & Development

Depreciation, Depletion & Amortization

SGA Expense to Gross Profit Ratio

R&D To Gross Profit Ratio

DDA To Gross Profit Ratio

Operating Expenses Total

Operating Profits/Loss

Operational Expenses

Concept 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009

Interest Expenses

Interest Expenses To Operating Income %

No data

Other Expense/Income

Interest & Other Expense/Income

Concept 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009

Income/Loss

Pretax Income

Income Tax

Net Profits/Loss

Pretax Income YoY Change

Income Tax Rate

No data

Net Profits/Loss YoY Change

Basic EPS

No data

Net Income To Revenue Ratio

Pretax & Net Income

Concept 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009

Assets & Liabilities

Cash & Short-Term Investments

Cash & Equivalents

Cash To Operating Expenses Ratio

Inventory

Receivables

Total Short-Term Assets

Property, Plant And Equipment

Long-Term Investments

Total Long-Term Assets

Total Assets

Net Income To Total Assets Percentage

Accounts Payable

Short-Term Debt

Long Term Debt Due

Total Short-Term Liabilities

Long-Term Debt

Other Long-Term Liabilities

Total Long-Term Liabilities

Total Liabilities

Short-Term To Long-Term Debt Ratio

Short-Term Assets To Debt Ratio

Long-Term Debt To Net Income Ratio

Assets & Liabilities

Concept 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009

Ownership

Basic Shares Outstanding

Diluted Shares Outstanding

No data

Preferred Stock

No data

Treasury Stock Shares

No data

Stock Issuance & Repurchase

Ownership Data

Concept 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009

Return On Shareholders' Equity

No data

Book Value

Free Cash Flow

Free Cash Flow YoY

Free Cash Flow Margin

Dividends

Dividends

No data

Stock Price

Market Cap: $70 Thousand

About Merion, Inc.

Merion, Inc. is a biotechnology company, which engages in the provision of health and nutritional supplements and personal care products. The company is headquartered in West Covina, California and currently employs 6 full-time employees. The company went IPO on 2014-12-03. The firm focuses on nutritional and beauty products, and OEM and packaging products. The firm mainly sells its products over the Internet directly to end-user customers through its Website, www.merionus.com, and to wholesale distributors through phone and electronic communication. The firm's major customers for its nutritional and beauty products are located in the Asian market, predominantly in the People's Republic of China. The firm's major customers for its original equipment manufacturer (OEM) and packaging products are located in the United States. The firm's products include Noir Naturel, Viwooba (1-3), Lady-S, ReMage-Power, Gold King, Tai Bao, and New Power. The firm also provides OEM and packaging services for hard capsules, tablets, solid beverages (sachet packaging), teabags, powder, granules, dietary supplements, soft gel capsules, and health foods.

Industry: Wholesale-Drugs, Proprietaries & Druggists' Sundries Peers: NewAge, Inc. UPD HOLDING CORP. CV Sciences, Inc. ESTEE LAUDER COMPANIES INC LiveWire Ergogenics, Inc. MusclePharm Corp RELIV INTERNATIONAL INC Horizon Kinetics Holding Corp